The ten-year rule revisited: Accuracy of clinicians’ estimates of life expectancy in patients with localized prostate cancer

Urology

Volumn 60, Issue 2, 2002, Pages 258-263

  Krahn, Murray D ^a   Bremner, Karen E ^c   Asaria, Jamil ^a   Alibhai, Shabbir M H ^a,c   Nam, Robert ^b,c   Tomlinson, George ^b,c   Jewett, Michael A S ^b,c   Warde, Padraig ^a,d   Naglie, Gary ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGE; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; HUMAN; LIFE EXPECTANCY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY;

AGE FACTORS; AGED; COMORBIDITY; FORECASTING; HUMANS; LIFE EXPECTANCY; MALE; MARKOV CHAINS; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIATION ONCOLOGY; TIME FACTORS; UROLOGY;

EID: 0036326544     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01712-0     Document Type: Article

References (26)

1. Guidelines on the management of prostate cancer
2. Prostate cancer: 6. Surgical treatment of localized disease
3. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer
4. Are we selecting the right patients for treatment of localized prostate cancer? Results of an actuarial analysis
5. Accuracy of predictions of survival in later stages of cancer
6. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer
7. Extent and determinants of error in doctors' prognoses in terminally ill patients. Prospective cohort study
8. Terminal cancer: Duration and prediction of survival time
9. The importance of coexistent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement
10. The impact of age and co-morbidity in the treatment of clinically localized prostate cancer - A decision analysis
11. Statistics Canada. Life tables, Canada and provinces 1985-1987
12. Long-term survival among men with conservatively treated localized prostate cancer
13. The meaning of life expectancy: What is a clinically significant gain?
14. Primer on medical decision analysis: Part 4 - Analyzing the model and interpreting the results
15. Gains in life expectancy from medical interventions - Standardizing data on outcomes
16. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer
17. How expert physicians would wish to be treated if they had genitourinary cancer
18. Differences between urologists in the United States and Canada in the approach to prostate cancer
19. British urological surgery practice: 1. Prostate cancer
20. Dilemmas in treating early prostate cancer: The evidence and a questionnaire survey of consultant urologists in the United Kingdom
21. A nationwide survey of practicing urologists: Current management of benign prostatic hyperplasia and clinically localized prostate cancer